{"id":"https://openalex.org/W70359207","doi":null,"title":"Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.","display_name":"Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W70359207","mag":"70359207","pmid":"https://pubmed.ncbi.nlm.nih.gov/16761509"},"language":"en","primary_location":{"id":"pmid:16761509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16761509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinski arhiv","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088970927","display_name":"A. Rustembegovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114755","display_name":"Anton Proksch Institut","ror":"https://ror.org/01ym1qc81","country_code":"AT","type":"nonprofit","lineage":["https://openalex.org/I4210114755"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Avdo Rustembegovic","raw_affiliation_strings":["Anton Proksch Institute of Drug and Alcohol Dependence, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anton Proksch Institute of Drug and Alcohol Dependence, Vienna, Austria","institution_ids":["https://openalex.org/I4210114755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061472565","display_name":"Emin Sofic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emin Sofic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089965361","display_name":"Ildiko Wichart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ildiko Wichart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5479,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.67822421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"60","issue":"4","first_page":"211","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.22439999878406525,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease-psychosis","display_name":"Parkinson's disease psychosis","score":0.906000018119812},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.7929999828338623},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.906000018119812},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.8730000257492065},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serum-lipids","display_name":"serum lipids","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lipoproteins","display_name":"lipoproteins","score":0.9520000219345093},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.5090000033378601},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9929999709129333},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.7730000019073486},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7955735921859741},{"id":"https://openalex.org/C2780613262","wikidata":"https://www.wikidata.org/wiki/Q223739","display_name":"Leptin","level":3,"score":0.7730149030685425},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7277653813362122},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7196745872497559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6575087904930115},{"id":"https://openalex.org/C139572402","wikidata":"https://www.wikidata.org/wiki/Q4927820","display_name":"Blood lipids","level":3,"score":0.6500764489173889},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.6328057050704956},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5698416829109192},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5121023654937744},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5070483684539795},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.454633891582489},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.44060325622558594},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.42993393540382385},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4240152835845947},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3638603091239929},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.35036149621009827},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3347659111022949},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.18353000283241272},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.132632315158844},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.08855786919593811}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020738","descriptor_name":"Leptin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:16761509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16761509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinski arhiv","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000767861","https://openalex.org/W2119997360","https://openalex.org/W2022694648","https://openalex.org/W2351439702","https://openalex.org/W3031155702","https://openalex.org/W2393924312","https://openalex.org/W2082322888","https://openalex.org/W2351110583","https://openalex.org/W2074044948","https://openalex.org/W1985583891"],"abstract_inverted_index":{"Weight":[0],"gain":[1],"is":[2],"a":[3,73,83],"common":[4],"adverse":[5],"effect":[6],"associated":[7],"with":[8,43,51,128,162,183,186,202],"the":[9,98,105],"use":[10],"of":[11,18,75,86,126,133,160,181],"most":[12],"typical":[13],"and":[14,35,82,96,100,107,116,122,138,156,173,199,204],"atypical":[15,52],"antipsychotic.":[16,53],"Aim":[17],"this":[19],"study":[20,55],"was":[21,148],"to":[22,104,189],"investigate":[23],"serum":[24,118,134,152,169,194],"prolactin,":[25,119,170,196],"leptin,":[26,120,153,171,195],"cholesterol,":[27,136],"triglyceride,":[28,137],"lipoproteins,":[29],"such":[30],"high":[31],"density":[32,37],"lipoprotein":[33,38],"(HDL),":[34],"low":[36],"(LDL)":[39],"levels":[40,140,155],"in":[41,144,168],"patients":[42,77,91,127,161,182],"Parkinson's":[44],"disease":[45],"(PD)-related":[46],"psychosis":[47,185],"during":[48],"long-term":[49],"medication":[50],"The":[54,90],"population":[56],"comprised":[57],"40":[58],"patients,":[59],"who":[60],"were":[61,92],"divided":[62],"into":[63],"4":[64],"groups:":[65],"olanzapine":[66,129,203],"(n=10),":[67,69],"risperidone":[68],"seroquel":[70,163,187],"(n=10)":[71],"monotherapy,":[72],"group":[74,85],"10":[76],"receiving":[78],"only":[79],"antiparkinson":[80],"drugs":[81],"control":[84],"8":[87],"healthy":[88],"persons.":[89],"evaluated":[93],"at":[94,97],"baseline":[95],"sixth":[99],"twelfth":[101],"week":[102],"according":[103],"Positive":[106],"Negative":[108],"Syndrome":[109],"Scale":[110],"(PANSS),":[111],"body":[112],"mass":[113],"index":[114],"(BMI),":[115],"fasting":[117],"lipids":[121],"lipoproteins":[123,174,198],"levels.":[124,175],"Treatment":[125],"caused":[130],"marked":[131],"increase":[132],"LDL,":[135],"leptin":[139],"(p<0,02).":[141],"No":[142],"changes":[143,167],"HDL":[145],"concentrations.":[146],"There":[147],"positive":[149],"relationship":[150],"between":[151],"lipid":[154],"BMI.":[157],"However,":[158],"treatment":[159,180],"did":[164],"not":[165],"cause":[166],"lipids,":[172,197],"Our":[176],"results":[177],"suggest":[178],"that":[179],"PD-related":[184],"appears":[188],"have":[190],"minimal":[191],"influence":[192],"on":[193],"BMI":[200],"compared":[201],"risperidone.":[205]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}